Vimarsana
Biggest News Aggregation in the World

Page 2 - Unrolling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Unrolling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Unrolling Today - Breaking & Trending Today

SlimLogix To Launch New Virtual Weight Loss Program - Vimarsana News

SlimLogix To Launch New Virtual Weight Loss Program

SlimLogix is now enrolling clients for its upcoming August program, a new 12-week, medically supervised, 100% online weight loss program and educational course, based on sound nutritional principles and grocery store, nutrient-dense foods. Oversight is provided by a physician and wearable Continuous Glucose Monitors (CGMs) are used to track blood sugar levels. Customized meal plans are created. The program does NOT use any medications, injections, diet foods, expensive supplements, or mea...

Marian University Preparatory School Expands to Serve Students in Grades K-10 in 31 States - Vimarsana News

Marian University Preparatory School Expands to Serve Students in Grades K-10 in 31 States

Marian University Preparatory School has announced a significant national expansion. The online faith-based school is now enrolling students in grades kindergarten through 10 in 31 additional states... | June 1, 2023

Ivonescimab Updated Data to be Featured at ASCO 2023 - Vimarsana News

Ivonescimab Updated Data to be Featured at ASCO 2023

Summit Therapeutics is Currently Enrolling in a Phase III Study with Additional Phase III Study Planned for Third Quarter 2023 for Ivonescimab ... | June 1, 2023

Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update

Two Phase 2 trials investigating -endoxifen in neoadjuvant setting initiated and are enrolling patientsFull enrollment of Phase 2 KARISMA mammographic breast density study expected by end of 2023Ended... | May 15, 2023

Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update - Vimarsana News

Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update

Four Phase 3 and two Phase 2 trials are now enrolling to evaluate domvanalimab-based combinations in lung and gastrointestinal cancers. The third dose-escalation cohort of ARC-20 for AB521, a... | May 9, 2023